耳鼻咽喉頭頸外科
輸血風險和不確定性
Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcome. (開啟新視窗)
來源: Int J Radiat Oncol Biol Phys 2009;73(2):391-8.
檢索: PubMed 18692326
DOI碼: 10.1016/j.ijrobp.2008.04.052
Transfusion as a predictor of recurrence and survival in head and neck cancer surgery patients. (開啟新視窗)
來源: J Otolaryngol Head Neck Surg 2010;39(5):516-22.
檢索: PubMed 20828514
Does transfusion improve the outcome for HNSCC patients treated with radiotherapy?—results from the randomized DAHANCA 5 and 7 trials. (開啟新視窗)
來源: Acta Oncol 2011;50(7):1006-14.
檢索: PubMed 21790306
DOI碼: 10.3109/0284186X.2011.592650
Transfusion of allogenic leukocyte-depleted packed red blood cells is associated with postoperative morbidity in patients undergoing oral and oropharyngeal cancer surgery. (開啟新視窗)
來源: Oral Oncol 2012;48(4):372-8.
檢索: PubMed 22182932
DOI碼: 10.1016/j.oraloncology.2011.11.020